Looking for more information to support your journey?

Browse the resources below to discover informative videos, quick facts and support information, disease specifics, and other helpful tools. The Ovarian Cancer Canada team is here to help if you have any questions.

Interested in a personalized selection of resources?

Tell us a little bit about what you’re looking for and our team will create a curated list just for you!

Get in touch
  • Category

  • Media Type

  • Clear filters
  • Video

    Understanding biomarkers in ovarian cancer

    Dr. Annie Leung, gynecologic oncologist, and Dr. Basile Tessier-Cloutier, gynecologic pathologist, share the basics of biomarkers: how they guide personalized therapies and help predict treatment response.

    Link

    Resource guide

    What are biomarkers?

    Biomarkers are an important part of ovarian cancer care, but many people are not familiar with what they actually are or what they may mean for their care. Learn more and discover the role biomarkers play.

    Link

    Resource guide

    Biomarkers in ovarian cancer

    What are biomarkers and what do they mean for your care? Learn more about how biomarkers relate to ovarian cancer and use this tool at your next appointment.

    Download

    Resource guide

    What is HRD testing for ovarian cancer?

    HRD describes if cancer cells can repair damage to their DNA. This helps determine if cancer will respond better to certain treatments.

    Link

    Video

    HRD Testing

    What is homologous recombination deficiency (HRD) and why does it matter in ovarian cancer? Learn how testing works, what results may mean, and how it could affect decisions around treatment options.

    Link

    Resource guide

    HRD testing patient guide

    What is HRD testing and what does it mean for you? Learn more about HRD and use this guide as a reference tool at your doctor's appointment.

    Download

    Video

    Breakthroughs start with you

    CEO Tania Vrionis shares highlights of what we've accomplished together in the 2025 Report to the Community.

    Link

    Video

    Understanding BRCA and HRD in ovarian cancer

    30 years of genetics: the discovery of BRCA1 and BRCA2 gene mutations, and how genetic testing became a key part of ovarian cancer care.

    Link

    Video

    Your care, your voice

    Navigating ovarian cancer: clinical experts and women living with the disease discuss what person-centred care looks like at every stage of the journey

    Link

    Video

    Pragmatic clinical trials

    Bridging research and real world care: what makes pragmatic trials unique and why they are essential for testing ovarian cancer treatments in real-world settings

    Link